Condition: Non Small Cell Lung Cancer · EGFR Gene Mutation · ALK Gene Mutation · Sponsor: Hunan Province Tumor Hospital
The purpose of this study is to assess the Treatment Strategies and Survival Outcome for Non-small Cell Lung Cancer With Oncogenic Mutation.
This description comes directly from the study's public registry record.
Yongchang Zhang, MD · +8613873123436 · zhangyongchang@csu.edu.cn
Nong Yang, MD · +8613055193557 · yangnong0217@163.com
Always discuss trial participation with your own doctor first.
| Yongchang Zhang | Changsha, Hunan, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04322890